Interfin licenses Microgen's derivatives pricing tool
31 May 2007 | 1576 views | 0
Microgen announced today that Interfin Group S.A. an International Money Broker in Switzerland have purchased a license for Microgen DART.
Microgen DART provides the computational power, extensive range of instrument coverage, ease-of-use, accuracy of information and speed of response demanded in support of both Exchange Traded and OTC global derivatives businesses.
"We are delighted that Interfin have chosen Microgen DART to meet their derivatives pricing requirements" said Elizabeth Sipiere, Managing Director, Microgen Banking Systems. "Interfin are the latest organisation to contract to Microgen DART in the last few months, demonstrating the quality of both the product and the team behind it" she concluded.
Microgen DART, integrates with a range of market data providers including Reuters and Bloomberg, provides rapid generation of standard pricing models or complex mathematical routines.
"With its comprehensive instrument coverage, access to market data and real-time performance, DART provides us with a derivatives desktop platform that enables us not only to compete more successfully in existing markets, but also to enter new markets extending our product and service coverage" commented William Ponti, Manager, Interest Rate Derivatives.